Search

everythinglearnresearchcommunity

for

Search:↓

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

Radiotherapy was effective for treating a large scalp plaque of Bowen's disease when other treatments failed.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Current treatments for alopecia show no significant long-term benefits.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Tofacitinib may help treat severe hair loss, but more research is needed.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Different treatments for alopecia areata have unpredictable results and varying success rates.